Changes in Treatment Patterns and Overall Survival for Early-Stage Diffuse Large B Cell Lymphoma in the United States After Rituximab: A Population-Based Analysis

被引:0
|
作者
Haque, W. [1 ]
Tann, A. W. J. [2 ]
Szeja, S. [3 ]
Butler, E. B. [4 ]
Teh, B. S. [5 ]
机构
[1] Greater Houston Phys Med Assoc, Houston, TX USA
[2] Univ Texas Med Branch, Dept Radiat Oncol, Galveston, TX 77555 USA
[3] Univ Texas Med Branch, Galveston, TX 77555 USA
[4] Houston Methodist Hosp, Weil Cornell Med Coll, Houston, TX USA
[5] Houston Methodist Hosp, Houston, TX USA
关键词
D O I
10.1016/j.ijrobp.2016.06.420
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1007
引用
收藏
页码:S167 / S167
页数:1
相关论文
共 50 条
  • [1] Changes in treatment patterns and impact of radiotherapy for early stage diffuse large B cell lymphoma after Rituximab: A population-based analysis
    Haque, Waqar
    Dabaja, Bouthaina
    Tann, Anne
    Khan, Mohammad
    Szeja, Sean
    Butler, E. Brian
    Teh, Bin S.
    RADIOTHERAPY AND ONCOLOGY, 2016, 120 (01) : 150 - 155
  • [2] Rituximab for early-stage diffuse large-B-cell lymphoma
    Friedberg, Jonathan W.
    LANCET ONCOLOGY, 2006, 7 (05): : 357 - 359
  • [3] Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: a Dutch population-based study
    Brink, Mirian
    Kahle, Xaver U.
    Vermaat, Joost S. P.
    Zijlstra, Josee M.
    Chamuleau, Martine
    Kersten, Marie Jose
    Durmaz, Mujde
    Plattel, Wouter J.
    Lugtenburg, Pieternella J.
    Stevens, Wendy
    Mous, Rogier
    de Vries, Elisabeth G. E.
    van der Poel, Marjolein W. M.
    Panday, Prashant V. Nannan
    Huls, Gerwin
    van Meerten, Tom
    Nijland, Marcel
    BLOOD ADVANCES, 2021, 5 (15) : 2958 - 2964
  • [4] Changes in Treatment Patterns and Overall Survival in Patients With Early-Stage Non-Small Cell Lung Cancer in the United States After the Incorporation of Stereotactic Ablative Radiation Therapy: A Population-based Analysis
    Haque, Waqar
    Szeja, Sean
    Tann, Anne
    Kalra, Sarathi
    Teh, Bin S.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (03): : 259 - 266
  • [5] Rituximab use and survival after diffuse large B-cell or follicular lymphoma: a population-based study
    Keegan, Theresa H. M.
    Moy, Lisa M.
    Foran, James M.
    Alizadeh, Ash A.
    Chang, Ellen T.
    Shema, Sarah J.
    Schupp, Clayton W.
    Clarke, Christina A.
    Glaser, Sally L.
    LEUKEMIA & LYMPHOMA, 2013, 54 (04) : 743 - 751
  • [6] Impact of rituximab on treatment outcomes of patients with diffuse large b-cell lymphoma: a population-based analysis
    Lee, Linda
    Crump, Michael
    Khor, Sara
    Hoch, Jeffrey S.
    Luo, Jin
    Bremner, Karen
    Krahn, Murray
    Hodgson, David C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 158 (04) : 481 - 488
  • [7] Patient Survival With and Without Radiation Therapy for Early-Stage Diffuse Large B-Cell Lymphoma in the Era of PET and Rituximab
    McLaughlin, Christopher
    Ricco, Anthony
    Singh, Raj
    Mukhopadhyay, Nitai
    Skoro, Nevena
    Girma, Selamawit
    Deng, Xiaoyan
    Song, Shiyu
    ADVANCES IN RADIATION ONCOLOGY, 2021, 7 (04)
  • [8] Survival outcomes in diffuse large B-cell lymphoma patients with and without HIV in the United States from 2001 to 2016: a population-based analysis
    Valcarcel, Bryan
    Schonfeld, Sara J.
    Shiels, Meredith S.
    Castillo, Jorge J.
    Morton, Lindsay M.
    HAEMATOLOGICA, 2025, 110 (03) : 799 - 803
  • [9] Shorter Diagnosis-to-Treatment Interval in Diffuse Large B-Cell Lymphoma is Associated With Inferior Overall Survival in a Large, Population-Based Registry
    Blunt, Danielle N.
    Smyth, Liam
    Nagamuthu, Chenthila
    Gatov, Evgenia
    Croxford, Ruth
    Mozessohn, Lee
    Cheung, Matthew C.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (06): : 719 - 725
  • [10] Survival In Advanced Diffuse Large B-Cell Lymphoma In Pre- and Post-Rituximab Eras In The United States: A Population Based Study
    Bista, Amir
    Shafii, Bahman
    Shah, Binay K.
    BLOOD, 2013, 122 (21)